Palo Alto Today

By the People, for the People

Stock Markets

Recent news

Rubrik Emerges as Top AI Cybersecurity Stock Amid Industry Disruption

Wedbush analysts highlight Rubrik's strong vendor feedback and deal momentum as enterprise IT budgets surge for AI-driven security solutions.

Quantbot Technologies Reduces AppLovin Holdings

Hedge fund cuts stake in mobile tech company by over 50%

Strive Asset Management Invests $7.5M in AppLovin

Hedge fund takes stake in mobile tech company

Integrated Financial Solutions Inc. Invests in AppLovin Corporation

Hedge fund takes new position in mobile tech company

Rafferty Asset Management Boosts Stake in AppLovin

Institutional investor increases holdings in mobile tech company by over 200% in Q3

Tesla Director Sells Over $10 Million in Shares

Kathleen Wilson-Thompson, a Tesla board member, offloaded more than 25,000 shares of the electric vehicle maker's stock.

Rafferty Asset Management Reduces Stake in BridgeBio Pharma

Institutional investor sells nearly 45,000 shares of biotech company

Arete Research Upgrades AppLovin (NASDAQ:APP) Stock to 'Hold'

Analysts cite improving outlook for the mobile technology company's performance.

Cache Advisors LLC Reduces AppLovin Corporation Stake

Investment firm sells over 4,200 shares of mobile tech company in Q3 2026

Artisan Partners Trims Stake in Intapp, Inc.

The investment firm reduced its holdings in the cloud-based software provider by 47.1% in the third quarter.

Intech Investment Management Trims BridgeBio Pharma Stake

Institutional investor sells nearly 20,000 shares of biotech company

Longview Advantage ETF Sells 2,135 Shares of Palo Alto Networks

The ETF exited its position in the cybersecurity firm during the latest quarter.

Stifel Nicolaus Cuts Intapp (NASDAQ:INTA) Stock Price Target

Research firm cites concerns about the company's growth outlook

Morgan Stanley Raises BridgeBio Pharma Price Target to $98

Analysts see continued growth potential for the clinical-stage biotech company.

Financial Analysis: Whitehawk Therapeutics and Vincerx Pharma

Comparing the performance and outlook of two small-cap medical companies

American Century Companies Trims AppLovin Stake

Asset manager reduces holdings in mobile tech firm by 5.4% in third quarter

DNB Asset Management Boosts AppLovin Holdings by 82%

Institutional investor increases stake in mobile tech company as analysts remain bullish on growth prospects.

Xponance Inc. Boosts Stake in AppLovin Corporation

Investment firm increases holdings in mobile tech company by nearly 20%

Intapp Rises 10.3% on Analyst Upgrade

Wall Street Zen upgrades stock to strong-buy rating

Nvidia Leads Stock Market Higher

Meta Platforms' AI partnership with Nvidia boosts the chipmaker's stock and the broader market.